{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Neurologie : Questions médicales les plus fréquentes",
"headline": "Neurologie : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Neurologie : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-11",
"dateModified": "2025-03-06",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Neurologie"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Médecine",
"url": "https://questionsmedicales.fr/mesh/D008511",
"about": {
"@type": "MedicalCondition",
"name": "Médecine",
"code": {
"@type": "MedicalCode",
"code": "D008511",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "H02.403"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Neurologie",
"alternateName": "Neurology",
"code": {
"@type": "MedicalCode",
"code": "D009462",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Riley Bove",
"url": "https://questionsmedicales.fr/author/Riley%20Bove",
"affiliation": {
"@type": "Organization",
"name": "From the Department of Clinical Neurosciences (H.F.T.), Cumming School of Medicine, University of Calgary, Alberta, Canada; Department of Neurology (S.C.L., R.B.), and UCSF Weill Institute for Neurosciences (S.C.L., R.B.), Department of Neurology, University of California, San Francisco; Buck Institute for Research on Aging (S.C.L.), Novato, CA; Department of Neurology (J.W.), University of Pittsburgh Medical Center, PA; Department of Neurology (M.A.O.N.), Brigham and Women's Hospital, Boston, MA; Division of Neurology (E.B.), Department of Medicine, University of Toronto; and Krembil Brain Institute (E.B.), University Health Network, Toronto, Ontario, Canada."
}
},
{
"@type": "Person",
"name": "Sara C LaHue",
"url": "https://questionsmedicales.fr/author/Sara%20C%20LaHue",
"affiliation": {
"@type": "Organization",
"name": "From the Department of Clinical Neurosciences (H.F.T.), Cumming School of Medicine, University of Calgary, Alberta, Canada; Department of Neurology (S.C.L., R.B.), and UCSF Weill Institute for Neurosciences (S.C.L., R.B.), Department of Neurology, University of California, San Francisco; Buck Institute for Research on Aging (S.C.L.), Novato, CA; Department of Neurology (J.W.), University of Pittsburgh Medical Center, PA; Department of Neurology (M.A.O.N.), Brigham and Women's Hospital, Boston, MA; Division of Neurology (E.B.), Department of Medicine, University of Toronto; and Krembil Brain Institute (E.B.), University Health Network, Toronto, Ontario, Canada."
}
},
{
"@type": "Person",
"name": "David Benninger",
"url": "https://questionsmedicales.fr/author/David%20Benninger",
"affiliation": {
"@type": "Organization",
"name": "Service de neurologie, Département des neurosciences cliniques, CHUV, 1011 Lausanne."
}
},
{
"@type": "Person",
"name": "Lorenz Hirt",
"url": "https://questionsmedicales.fr/author/Lorenz%20Hirt",
"affiliation": {
"@type": "Organization",
"name": "Service de neurologie, Département des neurosciences cliniques, CHUV, 1011 Lausanne."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "The two faces of DJ-1D proteins.",
"datePublished": "2023-06-15",
"url": "https://questionsmedicales.fr/article/37330357",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.tplants.2023.06.005"
}
},
{
"@type": "ScholarlyArticle",
"name": "κ-Carrageenan inhibits the formation of advanced glycation end products in cakes: Inhibition mechanism, cake characteristics, and sensory evaluation.",
"datePublished": "2023-06-08",
"url": "https://questionsmedicales.fr/article/37517221",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.foodchem.2023.136583"
}
},
{
"@type": "ScholarlyArticle",
"name": "Resistance to Gemcitabine in Pancreatic Cancer Is Connected to Methylglyoxal Stress and Heat Shock Response.",
"datePublished": "2023-05-17",
"url": "https://questionsmedicales.fr/article/37408249",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/cells12101414"
}
},
{
"@type": "ScholarlyArticle",
"name": "Monitoring the Release of Methylglyoxal (MGO) from Honey and Honey-Based Formulations.",
"datePublished": "2023-03-22",
"url": "https://questionsmedicales.fr/article/36985830",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/molecules28062858"
}
},
{
"@type": "ScholarlyArticle",
"name": "Exogenous hydrogen sulfide and methylglyoxal alleviate cadmium-induced oxidative stress in Salix matsudana Koidz by regulating glutathione metabolism.",
"datePublished": "2023-02-02",
"url": "https://questionsmedicales.fr/article/36732696",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12870-023-04089-y"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Professions de santé",
"item": "https://questionsmedicales.fr/mesh/D006281"
},
{
"@type": "ListItem",
"position": 3,
"name": "Médecine",
"item": "https://questionsmedicales.fr/mesh/D008511"
},
{
"@type": "ListItem",
"position": 4,
"name": "Neurologie",
"item": "https://questionsmedicales.fr/mesh/D009462"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Neurologie - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Neurologie",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-17",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Neurologie",
"description": "Comment diagnostique-t-on la sclérose en plaques ?\nQuels tests pour diagnostiquer un AVC ?\nQuelles analyses pour la maladie d'Alzheimer ?\nComment évaluer une neuropathie périphérique ?\nQuels examens pour les migraines ?",
"url": "https://questionsmedicales.fr/mesh/D009462?mesh_terms=Pyruvaldehyde&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Neurologie",
"description": "Quels sont les symptômes de la sclérose en plaques ?\nComment se manifeste un AVC ?\nQuels signes indiquent une épilepsie ?\nQuels symptômes de la maladie de Parkinson ?\nQuels signes d'une neuropathie diabétique ?",
"url": "https://questionsmedicales.fr/mesh/D009462?mesh_terms=Pyruvaldehyde&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Neurologie",
"description": "Comment prévenir un AVC ?\nQuelles mesures pour prévenir la maladie d'Alzheimer ?\nComment réduire le risque d'épilepsie ?\nQuelles stratégies pour prévenir la sclérose en plaques ?\nComment prévenir la neuropathie diabétique ?",
"url": "https://questionsmedicales.fr/mesh/D009462?mesh_terms=Pyruvaldehyde&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Neurologie",
"description": "Quels traitements pour la sclérose en plaques ?\nComment traiter un AVC ?\nQuelles options pour l'épilepsie ?\nQuels traitements pour la maladie de Parkinson ?\nComment traiter une neuropathie périphérique ?",
"url": "https://questionsmedicales.fr/mesh/D009462?mesh_terms=Pyruvaldehyde&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Neurologie",
"description": "Quelles complications de la sclérose en plaques ?\nQuelles sont les complications d'un AVC ?\nQuels risques liés à l'épilepsie ?\nQuelles complications de la maladie de Parkinson ?\nQuelles complications de la neuropathie diabétique ?",
"url": "https://questionsmedicales.fr/mesh/D009462?mesh_terms=Pyruvaldehyde&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Neurologie",
"description": "Quels sont les facteurs de risque d'un AVC ?\nQuels facteurs de risque pour la maladie d'Alzheimer ?\nQuels risques associés à l'épilepsie ?\nQuels facteurs de risque pour la maladie de Parkinson ?\nQuels facteurs de risque pour la neuropathie diabétique ?",
"url": "https://questionsmedicales.fr/mesh/D009462?mesh_terms=Pyruvaldehyde&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on la sclérose en plaques ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'examen neurologique, IRM et tests de conduction nerveuse."
}
},
{
"@type": "Question",
"name": "Quels tests pour diagnostiquer un AVC ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un scanner cérébral et un examen neurologique sont essentiels pour diagnostiquer un AVC."
}
},
{
"@type": "Question",
"name": "Quelles analyses pour la maladie d'Alzheimer ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests cognitifs, IRM et analyses de biomarqueurs aident à diagnostiquer la maladie d'Alzheimer."
}
},
{
"@type": "Question",
"name": "Comment évaluer une neuropathie périphérique ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'évaluation inclut un examen physique, électromyogramme et tests de conduction nerveuse."
}
},
{
"@type": "Question",
"name": "Quels examens pour les migraines ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un examen clinique et parfois une IRM ou un scanner pour exclure d'autres causes."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes de la sclérose en plaques ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fatigue, troubles de la vision, engourdissements et problèmes d'équilibre sont fréquents."
}
},
{
"@type": "Question",
"name": "Comment se manifeste un AVC ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent une faiblesse soudaine, des troubles de la parole et des maux de tête."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une épilepsie ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des convulsions, des absences et des mouvements involontaires peuvent indiquer l'épilepsie."
}
},
{
"@type": "Question",
"name": "Quels symptômes de la maladie de Parkinson ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Tremblements, rigidité musculaire, lenteur des mouvements et troubles de l'équilibre sont courants."
}
},
{
"@type": "Question",
"name": "Quels signes d'une neuropathie diabétique ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Engourdissements, picotements et douleurs dans les pieds et les mains sont des signes fréquents."
}
},
{
"@type": "Question",
"name": "Comment prévenir un AVC ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Adopter un mode de vie sain, contrôler la pression artérielle et éviter le tabac."
}
},
{
"@type": "Question",
"name": "Quelles mesures pour prévenir la maladie d'Alzheimer ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Exercice régulier, alimentation équilibrée et stimulation cognitive peuvent aider."
}
},
{
"@type": "Question",
"name": "Comment réduire le risque d'épilepsie ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les traumatismes crâniens et gérer les facteurs de risque comme l'alcool."
}
},
{
"@type": "Question",
"name": "Quelles stratégies pour prévenir la sclérose en plaques ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de méthode de prévention prouvée pour la sclérose en plaques."
}
},
{
"@type": "Question",
"name": "Comment prévenir la neuropathie diabétique ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Contrôler la glycémie, adopter une alimentation saine et faire de l'exercice régulièrement."
}
},
{
"@type": "Question",
"name": "Quels traitements pour la sclérose en plaques ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des médicaments immunomodulateurs et des thérapies symptomatiques."
}
},
{
"@type": "Question",
"name": "Comment traiter un AVC ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement peut inclure des médicaments thrombolytiques et une rééducation précoce."
}
},
{
"@type": "Question",
"name": "Quelles options pour l'épilepsie ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des médicaments antiépileptiques et parfois la chirurgie."
}
},
{
"@type": "Question",
"name": "Quels traitements pour la maladie de Parkinson ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements comprennent des médicaments dopaminergiques et des thérapies physiques."
}
},
{
"@type": "Question",
"name": "Comment traiter une neuropathie périphérique ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement vise à gérer la douleur et peut inclure des médicaments et des thérapies physiques."
}
},
{
"@type": "Question",
"name": "Quelles complications de la sclérose en plaques ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure des infections, des troubles de la mobilité et des douleurs chroniques."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications d'un AVC ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des troubles de la parole, des problèmes de mobilité et des infections."
}
},
{
"@type": "Question",
"name": "Quels risques liés à l'épilepsie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les risques incluent des blessures lors des crises et des complications psychologiques."
}
},
{
"@type": "Question",
"name": "Quelles complications de la maladie de Parkinson ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent être des troubles de la déglutition, des chutes et des infections."
}
},
{
"@type": "Question",
"name": "Quelles complications de la neuropathie diabétique ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des infections, des ulcères et des amputations dans les cas graves."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque d'un AVC ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Hypertension, diabète, tabagisme et antécédents familiaux augmentent le risque d'AVC."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour la maladie d'Alzheimer ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Âge avancé, antécédents familiaux et facteurs cardiovasculaires sont des risques connus."
}
},
{
"@type": "Question",
"name": "Quels risques associés à l'épilepsie ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents de traumatismes crâniens et d'alcoolisme augmentent le risque d'épilepsie."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour la maladie de Parkinson ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge, les antécédents familiaux et l'exposition à des toxines sont des facteurs de risque."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour la neuropathie diabétique ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mauvais contrôle de la glycémie, l'hypertension et le tabagisme augmentent le risque."
}
}
]
}
]
}
Despite the documented bi-enzymatic mode of methylglyoxal detoxification, the single-step catalysis of methylglyoxal by DJ-1/Pfp-I domain containing proteins has been in the limelight. Prasad et al. r...
Inhibiting the formation of advanced glycation end products (AGEs) in the heat-processed food can reduce health risks related to diabetic complications. However, additives used for this purpose may al...
Pancreatic ductal adenocarcinoma (PDAC) is a fatal disease with poor prognosis. Gemcitabine is the first-line therapy for PDAC, but gemcitabine resistance is a major impediment to achieving satisfacto...
Cadmium (Cd) is a highly toxic element for plant growth. In plants, hydrogen sulfide (H...
Cd treatment significantly increased the reactive oxygen species (ROS) levels and malondialdehyde (MDA) content, but decreased the growth parameters in S. matsudana. However, NaHS and MG supplementati...
The present study illustrated the crucial roles of H...
Progression to type 1 diabetes has emerged as a complex process with metabolic alterations proposed to be a significant driver of disease. Monitoring products of altered metabolism is a promising tool...
We tested their ability to predict risk of disease and discriminate which individuals with autoimmunity will progress to type 1 diabetes. We measured serum MG-AGEs from 141 individuals without type 1 ...
We examined the association of MG-AGEs with type 1 diabetes. MG-AGEs did not correlate with HbA1c or differ between stages 1, 2, and 3 type 1 diabetes. Yet, RNA MG-AGEs were significantly associated w...
MG-AGEs were able to discriminate which individuals with autoantibodies would progress at a faster rate to stage 3 type 1 diabetes providing a potential new clinical biomarker for determining rate of ...
The aim of this study was to investigate the antiglycation activity and mechanism of two identified peptides, Valine-Valine-Phenylalanine-Proline-Glycine-Cysteine-Proline-Glutamic acid (VVFPGCPE) and ...
Glyoxal (Gly) and methylglyoxal (Mgly) are key precursors globally for secondary organic aerosol (SOA) formation. These two species were often thought to be formed in the atmosphere via photochemical ...
Elevated methylglyoxal levels contribute to ammonium-induced growth disorders in Arabidopsis thaliana. Methylglyoxal detoxification pathway limitation, mainly the glyoxalase I activity, leads to enhan...
Methylglyoxal (MGO), a cytotoxic metabolite of glycolysis, can cause endothelial cells impairment, which is tightly associated with diabetic vascular complication. Umbelliferone, a derivative of couma...